RAMANUJAM NARAYANAN

About

I am a medical professional with an undergraduate degree in medicine cum surgery, and a postgraduate specialization in Pharmacology, both from Sri Ramachandra University (Deemed), Chennai, and a Doctorate in Philosophy in the Faculty of Basic Medical Sciences from the Tamil Nadu Dr MGR Medical University, Chennai. I have also an additional certificate diploma in clinical research from Med-varsity & Apollo Hospitals, Hyderabad, India. My areas of research interests include pre-clinical and clinical neuropsychopharmacology and cognitive toxicology. I also have completed my Postgraduate Diploma in Bioethics from Bharatiyar University, Coimbatore. I am positive in promotion of academic research and learning in my areas of expertise.

Employment

• PSG Institute of Medical Sciences & Research Professor
  2023 - Present
• PSG Institute of Medical Sciences and Research ASSOCIATE PROFESSOR
  2018 - 2023
• Tamil Nadu Dr. M.G.R. Medical University Affiliated University
  2011 - Present
• PSG Institute Of Medical Sciences And Research ASSISTANT PROFESSOR
  2011 - 2018
• Sri Ramachandra Medical College and Research Institute DEMONSTRATOR / TUTOR
  2008 - 2011

Education

• Sri Ramachandra University M.D.
  2008 - 2011
• Apollo Hospitals FELLOW IN CLINICAL RESEARCH
  2008 - 2009
• Sri Ramachandra University MBBS
  2001 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• Behavioural toxicodynamics and kinetic profiling of PCB congeners in Swiss Albino mouse dosed with Aroclor 1232 through inhalational route: a pivotal risk assessment study
  Xenobiotica 2026 DOI: 10.1080/00498254.2026.2621365
  +Save
• Genetic Influence of CYP2D6 on Risperidone Metabolism: Pharmacokinetic and Pharmacodynamic Study in a Healthy South Indian Population
  Human Psychopharmacology: Clinical and Experimental 2026 DOI: 10.1002/hup.70044
  +Save
• Transgenerational toxicity of Aroclor 1232 by inhalational route in mouse model
  Toxicology Reports 2025 DOI: 10.21203/rs.3.rs-4820257/v1
  +Save
• Behavioral toxicity and pharmacokinetics of PCB 77 and PCB 180 in Swiss albino mouse: A single dose inhalation toxicity risk assessment
  2024 DOI: 10.22541/au.170665667.76178318/v1
  +Save
• Behavioral Toxicodynamics and Kinetic profiling of PCB congeners in Swiss albino mouse dosed with Aroclor 1232 through inhalational route: A pivotal risk assessment study
  Research Square 2024 DOI: 10.21203/rs.3.rs-4715900/v1
  +Save
• Behavioral toxicity and pharmacokinetics of PCB 77 and PCB 180 in Swiss albino mouse A single dose inhalation toxicity risk assessment
  Research Square 2022 DOI: 10.21203/rs.3.rs-1425455/v1
  +Save
• Design and development of whole-body rodent inhalation chamber for exposure to Aroclor 1232 in Swiss albino mice
  International Journal of Environmental Science and Technology 2021 DOI: 10.1007/s13762-021-03515-8
  +Save
• Persistent organic pollutants-environmental risk factors for diabetes mellitus? – A population-based study
  Indian Journal of Occupational and Environmental Medicine 2021 DOI: 10.4103/ijoem.ijoem_337_20
  +Save
• ETHICAL CONSTRUCTS OF PHARMACOGENETIC STUDIES: A mini-network meta-analysis
  2018
  +Save
• Prenatal and postnatal exposures to PCBs: effect on behavior and neurochemicals in mice across one generation
  2017
  +Save